Navigation Links
TASQ in Medical Technology

Positive Clinical Data for TASQ - Active Biotech's Novel Treatment of Prostate Cancer

LUND, Sweden, March, 9, 2007-Active Biotech (ACTI.ST), today announced new positive clinical data from the Phase Ib study of TASQ, for the treatment of prostate cancer. By step-wise dose escalation, a safe dose of 1 mg/day of TASQ was achieved, which corresponds to a doubling of the previously r...

Active Biotech's I-3D Micro-dosing Clinical Trial Concluded

...eted therapy, the primary indication being renal cancer. Further key projects in clinical development comprise the three orally administered compounds tasq for prostate cancer 57-57 for SLE and RhuDex® for RA. In addition, the preclinical development of the I-3D project is being conducted in cooperati...

Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)

...eted therapy, the primary indication being renal cancer. Further key projects in clinical development comprise the three orally administered compounds tasq for prostate cancer, 57-57 for SLE and RhuDex(R) for RA. In addition, the preclinical development of the I-3D project is being conducted in cooperatio...

New Positive Pre-clinical Data for Active Biotech's RA Project I-3D

...eted therapy, the primary indication being renal cancer. Further key projects in clinical development comprise the three orally administered compounds tasq for prostate cancer, 57-57 for SLE and RhuDex® for RA. In addition, the preclinical development of the I-3D project is conducted in cooperation wi...

Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation

...eted therapy, the primary indication being renal cancer. Further key projects in clinical development comprise the three orally administered compounds tasq for prostate cancer, 57-57 for SLE and RhuDex® for RA. In addition, the preclinical development of the I-3D project is conducted in cooperation wi...
TASQ in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...atients II-59 Panacea Pharmaceuticals Identifies Blood Protein for Early Prostate Cancer Detection II-60 Active Biotech Reveals Results of tasq Phase I Study for Prostate Cancer II-61 Positive Results of Combined Hormone and Radiation Therapies in Locally Advanced Prostate Cancer I...
Other Tags
(Date:8/3/2015)... ... August 03, 2015 , ... The Workgroup for Electronic Data Interchange ... to create efficiencies in healthcare information exchange, announced the release of its findings from ... Human Services (HHS) Secretary, WEDI shared survey results and recommendations , ...
(Date:8/3/2015)... Angeles, California (PRWEB) , ... August 03, 2015 ... ... on the Atlanta Journal Constitution, the new Lifetime reality series, “Atlanta Plastic” ... who performs and who receives plastic surgery, with its predominantly African-American cast of ...
(Date:8/3/2015)... ... August 03, 2015 , ... According to an opinion piece published July 28 by ... to one pound of weight loss may not be accurate. While this system may work ... pound of fat varies – based both on the individual and at what point that ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... They know ... Providence St. Vincent Medical Center offers some of the best care in the ... neurosurgeon and neurointerventionalist, achieved the fastest average blood clot removal time in the country. ...
(Date:8/3/2015)... Pennsylvania (PRWEB) , ... August 03, 2015 , ... Bayer ... Yaz and Yasmin related claims in which a claimant alleged to have suffered an ... related to the birth control pills, Yaz, Yasmin and Ocella, has been ongoing for ...
Breaking Medicine News(10 mins):Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 4Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Article Dispelling Weight Loss Myth Correctly Emphasizes the Complicated and Difficult Nature of Weight Loss, Says Dr. Michael Feiz 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... China , 31 de julio de 2015 /PRNewswire/ ... Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 de ... . La conferencia celebra su décimo aniversario ... ha convertido en una de las reuniones anuales más ... y es una de las conferencias científicas más dinámicas, ...
(Date:7/31/2015)... de 2015 A 10 a. Conferência ... pela BGI de 22-25 de outubro de 2015, em ... conferência está celebrando seu 10 o. aniversário este ano. ... uma das reuniões mais influentes do mundo no ramo ... entusiastas e prazerosos. A ICG-10 se ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
Other Contents